We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
D01001 | Defensin (human) HNP-2 | 3371.0 | C147H217N43O37S6 | Inquiry |
D01002 | Defensin-1 (human) HNP-1 | 3442.1 | C150H222N44O38S6 | Inquiry |
D01003 | α-Defensin 6 | 3708.27 | C156H228N46O46S7 | Inquiry |
D01004 | Defensin HNP-3 (human) | 3486.09 | C151H222N44O40S6 | Inquiry |
D01005 | Corticostatin I (rabbit) | 3997.64 | Inquiry | |
D01007 | rec beta-Defensin 1 (human) | Inquiry | ||
D01008 | rec beta-Defensin 2 (human) | Inquiry | ||
D01009 | Retrocyclin-1 | 1918.42 | Inquiry | |
D06001 | Defensin-like peptide 1 | Inquiry | ||
D06002 | Defensin-like peptide 2/4 | Inquiry | ||
D06003 | Defensin-like protein 2 | Inquiry | ||
D06004 | Defensin-like protein 4 | Inquiry | ||
D06005 | Defensin-like protein 16 | Inquiry | ||
D06006 | Alpha-defensin-related sequence 10 | Inquiry | ||
D06007 | Alpha-defensin-related sequence 2 | Inquiry | ||
D06008 | Defensin-like protein 17 | Inquiry | ||
D06009 | Defensin-like protein 1 | Inquiry | ||
D06010 | Defensin-like protein 5 | Inquiry | ||
D06011 | Defensin-like protein 13 | Inquiry | ||
D06012 | CHRG01; Human β-Defensin 3 (hBD3) Derivative | 1662 | Inquiry |
From plants and insects to people, a variety of creatures have a collection of tiny, cysteine-rich peptides called defensins. Mostly recognized for their antibacterial action, these compounds are essential for the natural immune system. Their capacity to fight a broad spectrum of pathogens—including fungus, viruses, and bacteria—makes them essential for preventing diseases. Defensins, however, also play a role in a variety of other biological events including immunological control and tissue healing.
The body's initial line of defense against infections is the innate immune system, which includes the tiny peptides known as defensins. They are distinguished by their capacity to form a β-sheet shape maintained by disulfide bonds and their cysteine-rich structure, which usually consists of 18–45 amino acids. α-defensins and β-defensins are the two primary types of defensins; they have different structures and functions but have comparable antibacterial properties. The skin, mucosal surfaces, and immune cells such as neutrophils and epithelial cells are among the tissues that generate defensins.
Cysteine residues that form disulfide bonds give defensins their distinctive β-sheet structure, which is essential to their antibacterial activity. Defensins' capacity to interact with microbial membranes and compromise their integrity is attributed to the configuration of these disulfide bonds. Although α-defensins and β-defensins have somewhat different structures, they can both create amphipathic structures, which are hydrophilic and hydrophobic areas that enable them to enter into and disrupt pathogen lipid membranes.
Alpha defensins are typically found in neutrophils, paneth cells, and other immune cells. They are known to directly combat microorganisms, especially fungus and bacteria. The function of alpha defensins in mucosal immunity, particularly in the gut, where they aid in pathogen defense, has been well investigated. Alpha defensins have antibacterial properties, but they also modulate the immune system and may attract more immune cells to infection or damage areas.
Pro-defensins, which must be converted into their active form, are the predecessors of alpha defensins. Alpha defensins are usually activated when infection or when inflammatory signals are present.
The epidermis, airways, and genitourinary tract are among the tissues that contain beta defensins. As a first line of defense against microbial invasion, beta defensins play a significant role in the innate immune response, especially in the skin and mucosal tissues. These peptides aid in maintaining a healthy microbial population on epithelial surfaces and are generated in reaction to infection or damage.
Their unique structural makeup and somewhat diverse antibacterial range set beta defensins apart from alpha defensins. In order to preserve mucosal immunity, beta defensins are normally produced by epithelial cells, such as those found in the gastrointestinal tract, skin, and airways.
Although defensins have several uses, they are mostly associated with the immune system. Among their principal responsibilities are:
Antimicrobial Activity: By rupturing the cell membranes of bacteria, fungi, and viruses, defensins directly destroy them. Defensins' cationic and amphipathic properties enable them to enter microbial membranes and cause cell lysis.
Immune Modulation: By drawing immune cells to infection sites, including T cells and neutrophils, defensins actively contribute to immunological control. They also have an impact on the synthesis of cytokines, which are immune response-related signaling molecules.
Tissue Repair: Defensins have antibacterial and immune-modulatory properties, but they also play a role in wound healing. By encouraging the development of endothelial cells, which are crucial for the formation of new blood vessels during tissue regeneration, they aid in tissue healing.
Inflammation Regulation: By triggering or blocking different signaling pathways that govern the immune response, defensins may alter inflammation. They thereby have a significant role in both acute and long-term inflammatory processes.
Defensins function by attacking harmful bacteria' membranes. They may attach to the negatively charged lipids present in the membranes of viruses, fungi, and bacteria because of their cationic charge. Defensins attach to the membrane and create holes that compromise the membrane's integrity. This ultimately results in cell death and the leaking of essential biological components.
Apart from their direct antibacterial actions, defensins also have the ability to regulate the immune system. They have the ability to draw immune cells, including neutrophils and macrophages, to the site of damage or infection, where they stimulate the immune system and cause inflammation. The body's defensive systems are further enhanced by this immunological regulation.
The natural immune system of the body depends critically on defensins. Defensins provide instantaneous protection against infections unlike antibodies, which are components of the adaptive immune system and require time to mature. Maintaining a healthy immune response depends on their direct killing of bacteria as well as their immune-modulating action.
Immunosurveillance—the process by which the immune system detects and destroys altered or contaminated cells—also involves defensins. Defensins assist to coordinate the immune response to infections and injuries by interacting with many immune cells and encouraging the release of cytokines.
Defensins are found in the skin, where they play a crucial role in defending against microbial pathogens that come into contact with the skin's surface. They help to maintain a healthy balance of microbes on the skin, preventing the overgrowth of harmful pathogens.
The alpha defensin ELISA (enzyme-linked immunosorbent assay) test is a crucial instrument for determining defensin levels, especially alpha defensins. Alpha defensin levels in a variety of biological samples, including serum, urine, and wound exudate, may be determined with this laboratory test. Since elevated alpha defensin levels are often linked to infections or inflammatory illnesses, this test may be used to diagnose and track diseases such cystic fibrosis, inflammatory bowel disease (IBD), and periodontal disease.
A key component of the body's defense against infectious pathogens is defensins. But they also play important roles in a number of disorders, both in pathogenic and preventive capacities:
Infections: In order to protect against bacterial, fungal, and viral infections, defensins are essential. People may be more prone to infections in situations when their defensins are lacking or malfunctioning.
Autoimmune disorders: Because defensins modulate the immune response, autoimmune disorders may arise as a result of aberrant defensin synthesis or activity. For example, lupus models and rheumatoid arthritis have been shown to have dysregulation of defensin expression.
Cancer: Although research is still ongoing, certain studies have shown that defensins may contribute to tumor suppression or the advancement of specific malignancies.
Wound Healing: By encouraging cell migration and angiogenesis, defensins play a crucial role in tissue regeneration and wound repair, hastening the healing process.
USA
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-624-4882
Fax: 1-631-614-7828
Email: info@creative-peptides.com
Germany
Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main
Email: info@creative-peptides.com